retatrutide phase 2 weight loss is investigational and is not FDA approved. In TRANSCEND-T2D-1, investigators randomized 537 adults with type diabetes inadequately controlled by diet and exercise in a 40-week, double-blind, placebo-controlled 3 trial Triple hormone receptor agonist retatrutide

doi: 10.1007/s00125-004-1379-6 40 GaspariTBrdarMLeeHWSpizzoIHuYWiddopRE

Basing this calculation on corrected bodyweight (adjusted or ideal) or FFM, or setting an absolute protein target of 80120 g/day (or 16 %24 % energy on a 2000 kcal/day diet) have been proposed as alternative approaches, although a clear consensus on the optimal method has yet to be reached [27]

SLU-PP-332

Theyre not replacing the need to train and eat right

Instead of the natural hormone lasting minutes, semaglutide persists for roughly a week

For men interested in the hormonal angle, understanding HRT and GLP-1 together provides important context on safety considerations, expected outcomes, and how to approach combination therapy responsibly